Cargando…

The Immune Landscape of Breast Cancer: Strategies for Overcoming Immunotherapy Resistance

SIMPLE SUMMARY: Immunotherapy is a rapidly advancing field in breast cancer treatment, however, it encounters many obstacles that leave open gateways for breast cancer cells to resist novel immunotherapies. It is believed that the tumor microenvironment consisting of cancer, stromal, and immune cell...

Descripción completa

Detalles Bibliográficos
Autores principales:	Retecki, Kuba, Seweryn, Milena, Graczyk-Jarzynka, Agnieszka, Bajor, Malgorzata
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2021
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8657247/ https://www.ncbi.nlm.nih.gov/pubmed/34885122 http://dx.doi.org/10.3390/cancers13236012

Ejemplares similares

Targeting Negative and Positive Immune Checkpoints with Monoclonal Antibodies in Therapy of Cancer
por: Marhelava, Katsiaryna, et al.
Publicado: (2019)

PD-L1 CAR effector cells induce self-amplifying cytotoxic effects against target cells
por: Bajor, Malgorzata, et al.
Publicado: (2022)

Triple Combination of Ascorbate, Menadione and the Inhibition of Peroxiredoxin-1 Produces Synergistic Cytotoxic Effects in Triple-Negative Breast Cancer Cells
por: Bajor, Malgorzata, et al.
Publicado: (2020)

PRDX-1 Supports the Survival and Antitumor Activity of Primary and CAR-Modified NK Cells under Oxidative Stress
por: Klopotowska, Marta, et al.
Publicado: (2022)

Targeting peroxiredoxin 1 impairs growth of breast cancer cells and potently sensitises these cells to prooxidant agents
por: Bajor, Malgorzata, et al.
Publicado: (2018)

P1376: IDENTIFICATION OF SURFACEOME CHANGES IN CD19 CAR-T THERAPY-RESISTANT LYMPHOMA CELLS
por: Krawczyk, Marta, et al.
Publicado: (2023)

Resistance and Overcoming Resistance in Breast Cancer
por: Luque-Bolivar, Andrea, et al.
Publicado: (2020)

Current Landscape of Therapeutic Resistance in Lung Cancer and Promising Strategies to Overcome Resistance
por: Ashrafi, Adnin, et al.
Publicado: (2022)

The Great War of Today: Modifications of CAR-T Cells to Effectively Combat Malignancies
por: Zhylko, Andriy, et al.
Publicado: (2020)

Editorial: Strategies to overcome tumor evasion and resistance to immunotherapies by targeting immune suppressor cells
por: Saida, Yu, et al.
Publicado: (2023)

New insights into redox homeostasis as a therapeutic target in B-cell malignancies
por: Graczyk-Jarzynka, Agnieszka, et al.
Publicado: (2017)

Editorial: Gastrointestinal cancer immunotherapy: from drug resistance mechanisms to overcoming strategies
por: Shi, Tao, et al.
Publicado: (2023)

Using triple radio-immunotherapy to overcome cancer immunotherapy resistance
por: Zhang, Zengfu, et al.
Publicado: (2023)

Recent and Future Strategies to Overcome Resistance to Targeted Therapies and Immunotherapies in Metastatic Colorectal Cancer
por: Dazio, Giulia, et al.
Publicado: (2022)

New Strategies to Overcome Resistance to Chemotherapy and Immune System in Cancer
por: Riganti, Chiara, et al.
Publicado: (2019)

Combinatorial immunotherapies overcome MYC-driven immune evasion in triple negative breast cancer
por: Lee, Joyce V., et al.
Publicado: (2022)

Immune landscape and immunotherapy for penile cancer
por: Tang, Yaxiong, et al.
Publicado: (2022)

Overcoming Immunotherapy Resistance With Radiation Therapy and Dual Immune Checkpoint Blockade
por: Davidson, Tara, et al.
Publicado: (2022)

Barriers to overcoming immunotherapy resistance in glioblastoma
por: Gillette, Julia S., et al.
Publicado: (2023)

Immunotherapy for non-small cell lung cancers: biomarkers for predicting responses and strategies to overcome resistance
por: Pu, Xingxiang, et al.
Publicado: (2018)

Therapeutic Strategies for Overcoming Immunotherapy Resistance Mediated by Immunosuppressive Factors of the Glioblastoma Microenvironment
por: Miyazaki, Tsubasa, et al.
Publicado: (2020)

Strategies to Overcome Resistance to Immune-Based Therapies in Osteosarcoma
por: Hattinger, Claudia Maria, et al.
Publicado: (2023)

Normalizing the Microenvironment Overcomes Vessel Compression and Resistance to Nano‐immunotherapy in Breast Cancer Lung Metastasis
por: Mpekris, Fotios, et al.
Publicado: (2020)

Immunotherapy with CAR-Modified T Cells: Toxicities and Overcoming Strategies
por: Sun, Shangjun, et al.
Publicado: (2018)

The neoepitope landscape of breast cancer: implications for immunotherapy
por: Narang, Pooja, et al.
Publicado: (2019)

A review of strategies to overcome immune resistance in the treatment of advanced prostate cancer
por: Sooi, Kenneth, et al.
Publicado: (2023)

Author Correction: Combinatorial immunotherapies overcome MYC-driven immune evasion in triple negative breast cancer
por: Lee, Joyce V., et al.
Publicado: (2022)

The Landscape of Immunotherapy Resistance in NSCLC
por: Frisone, Daniele, et al.
Publicado: (2022)

Nanoparticles overcome adaptive immune resistance and enhance immunotherapy via targeting tumor microenvironment in lung cancer
por: Zhang, Xin, et al.
Publicado: (2023)

Immunotherapy in triple-negative breast cancer: Insights into tumor immune landscape and therapeutic opportunities
por: Ribeiro, Rita, et al.
Publicado: (2022)

The immune landscape of human tumors: Implications for cancer immunotherapy
por: Bindea, Gabriela, et al.
Publicado: (2014)

The Role of Immunotherapy to Overcome Resistance in Viral-Associated Head and Neck Cancer
por: Pharaon, Rebecca R., et al.
Publicado: (2021)

Smart drug delivery systems to overcome drug resistance in cancer immunotherapy
por: Yi, Wenzhe, et al.
Publicado: (2023)

Mechanisms of tumor resistance to immune checkpoint blockade and combination strategies to overcome resistance
por: Zhou, Xiaoting, et al.
Publicado: (2022)

Antibody-drug conjugates in breast cancer: overcoming resistance and boosting immune response
por: Chang, Hannah L., et al.
Publicado: (2023)

Immune cell landscape and immunotherapy of medulloblastoma
por: Zhang, Jin, et al.
Publicado: (2021)

Bcl-2 Inhibition to Overcome Resistance to Chemo- and Immunotherapy
por: García-Aranda, Marilina, et al.
Publicado: (2018)

Drugging the Epigenome: Overcoming Resistance to Targeted and Immunotherapies in Melanoma
por: Hanly, Ailish, et al.
Publicado: (2021)

A new approach to overcoming resistance to immunotherapy: nanotechnology
por: Shao, Jiangbo, et al.
Publicado: (2023)

Mechanisms Behind the Resistance to Trastuzumab in HER2-Amplified Breast Cancer and Strategies to Overcome It
por: Luque-Cabal, María, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_lrcg7es1kpcl2bb81b3sk6d6dg